Non-Invasive Prenatal Testing Market Growth Key Futuristic Trends And Competitive Landscape 2020-2023

The Business Research Company offers "Non-Invasive Prenatal Testing Global Market Report 2020-30: COVID-19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trend s and strategies that players in the market can adopt.

The global non-invasive prenatal testing market is expected to grow from $1.9 billion in 2019 to $2.2 billion in 2020 at a compound annual growth rate (CAGR) of 18.1%. The growth of this market is mainly due to high-precision screening with low risk of infection compared to invasive procedures. The market is then expected to recover and grow at a CAGR of 14.7% from 2021 and reach $3.4 billion in 2023.

Place a DIRECT PURCHASE ORDER of the report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2492

The noninvasive prenatal testing market consists of sales of non-invasive prenatal testing kits, instruments and related services. Noninvasive prenatal testing kits and equipment are used to diagnose genetic abnormalities, mainly chromosome defects in fetus in first trimester of pregnancy. Noninvasive prenatal testing includes ultrasound detection, fetal cells in maternal blood tests, cell-free DNA in maternal plasma tests and biochemical screening tests.

Next generation sequencing has increased the throughput, scalability, and speed, and further enables researchers to perform a wide range of applications and study biological systems at a higher level. Next generation sequencing is a platform that has enabled sequencing of thousands to millions of DNA molecules simultaneously.

Non-Invasive Prenatal Testing Market Segmentation:
By Type
1. Consumables,
2. Instruments.

By End User
1. Hospital,
2. Diagnostic Labs.

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report

Few Points From Table Of Content
1. Executive Summary
2. Non-Invasive Prenatal Testing Market Characteristics
3. Non-Invasive Prenatal Testing Market Size And Growth
4. Non-Invasive Prenatal Testing Market Segmentation
5. Non-Invasive Prenatal Testing Market Regional And Country Analysis
……
25. Non-Invasive Prenatal Testing Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Non-Invasive Prenatal Testing Market
27. Non-Invasive Prenatal Testing Market Trends And Strategies
28. Non-Invasive Prenatal Testing Market Future Outlook and Potential Analysis
29. Appendix

The report covers the trends and market dynamics of the noninvasive prenatal testing market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2492&type=smp

Some of the key players involved in the noninvasive prenatal testing market are Precision Biosciences, Promega, Juno Therapeutics, Intellia Therapeutics, Qiagen, GE Healthcare Lonza, Cellectis, Dharmacon, AstraZeneca, Agilent Technologies.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.